Your browser doesn't support javascript.
Bacterial but no SARS-CoV-2 contamination after terminal disinfection of tertiary care intensive care units treating COVID-19 patients.
Hofmaenner, Daniel A; Wendel Garcia, Pedro David; Duvnjak, Branko; Chakrakodi, Bhavya; Maier, Julian D; Huber, Michael; Huder, Jon; Wolfensberger, Aline; Schreiber, Peter W; Schuepbach, Reto A; Zinkernagel, Annelies S; Buehler, Philipp K; Brugger, Silvio D.
  • Hofmaenner DA; Institute of Intensive Care, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Wendel Garcia PD; Institute of Intensive Care, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Duvnjak B; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Chakrakodi B; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Maier JD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Huber M; Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
  • Huder J; Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
  • Wolfensberger A; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Schreiber PW; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Schuepbach RA; Institute of Intensive Care, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Zinkernagel AS; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Buehler PK; Institute of Intensive Care, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Brugger SD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. silvio.brugger@usz.ch.
Antimicrob Resist Infect Control ; 10(1): 11, 2021 01 12.
Article in English | MEDLINE | ID: covidwho-1028830
ABSTRACT

BACKGROUND:

In intensive care units (ICUs) treating patients with Coronavirus disease 2019 (COVID-19) invasive ventilation poses a high risk for aerosol and droplet formation. Surface contamination of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) or bacteria can result in nosocomial transmission.

METHODS:

Two tertiary care COVID-19 intensive care units treating 53 patients for 870 patient days were sampled after terminal cleaning and preparation for regular use to treat non-COVID-19 patients.

RESULTS:

A total of 176 swabs were sampled of defined locations covering both ICUs. No SARS-CoV-2 ribonucleic acid (RNA) was detected. Gram-negative bacterial contamination was mainly linked to sinks and siphons. Skin flora was isolated from most swabbed areas and Enterococcus faecium was detected on two keyboards.

CONCLUSIONS:

After basic cleaning with standard disinfection measures no remaining SARS-CoV-2 RNA was detected. Bacterial contamination was low and mainly localised in sinks and siphons.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacteria / Disinfection / Equipment Contamination / COVID-19 / Intensive Care Units Type of study: Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Antimicrob Resist Infect Control Year: 2021 Document Type: Article Affiliation country: S13756-021-00885-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacteria / Disinfection / Equipment Contamination / COVID-19 / Intensive Care Units Type of study: Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Antimicrob Resist Infect Control Year: 2021 Document Type: Article Affiliation country: S13756-021-00885-z